Anxo Martínez Ordóñez & Marcos Fernández Fondevila
Anxo Martínez Ordóñez & Marcos Fernández Fondevila
Endocrine Oncology Group (P1L3) & Molecular Metabolism (P0L4)
Theatre Room, CiMUS
Anxo Martínez Ordóñez: "Microenvironmental regulation of breast cancer metastasis by the POU1F1 transcription factor"

About
The POU1F1 deregulation induces profound phenotypic changes in breast cancer cells promoting proliferation, migration and site-directed metastasis. In addition to cancer cells, solid tumors have another type of cells, commonly called stroma, that includes macrophages and fibroblasts among others. In this talk, I will comment on how the stroma is reeducated by the POU1F1 to support and collaborate in cancer progression.
Bio
2009-2013: Biology Degree; University of Santiago de Compostela
2013-2014: Master's degree in biomedical research; University of Santiago de Compostela
2014: Xunta de Galicia and FPU predoctoral grants
2014-Present. PhD student in the Endocrine Oncology lab: "Breast cancer: role of Pit-1 and CXCR4/CXCL12 in the metastatic process".
2018: Publication as first author: "Breast cancer metastasis to liver and lung is facilitated by Pit-1/CXCL12/CXCR4 axis" Oncogene journal.
2018: Predoctoral stay at Sanford Burnham Prebys Medical Discovery Institute (La Jolla, CA, USA) working in hepatic tumor cell microenvironment with hepatic stellate cells (HSCs) (Jorge Moscat's lab).
Marcos Fernández Fondevila: "Activation of hepatic GPR55 receptor promotes non-alcoholic liver steatosis"
About
GPR55, a putative cannabinoid receptor, has been recently involved in energy homeostasis. However, its specific role in lipid metabolism in the liver remains unknown. In this talk, we will show some of our latest results in which we found that hepatic GPR55 modulates lipid metabolism, contributing to the pathogenesis of nonalcoholic fatty liver disease.
Bio
2010-2014: Biology Degree; University of Santiago de Compostela
2014-2015: Master's degree in Biomedical Research; University of Santiago de Compostela
2015-Present. PhD student in the Molecular Metabolism lab
2016: Xunta de Galicia and FPU predoctoral grants
2017: Publication of "Hepatic p63 regulates steatosis via IKKb/ER stress" in Nature Communications.
2017: Publication of "Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis" in Molecular Metabolism.
2018: Predoctoral stay at CIC bioGUNE (Bilbao, Basque Country, Spain) working in mouse models in nonalcoholic steatohepatitis.
